Barrington Research Reiterates Outperform on Marcus, Maintains $19 Price Target
Barrington Research analyst James Goss reiterates Marcus (NYSE:MCS) with a Outperform and maintains $19 price target.
Watching Arbor Realty Trust; NINGI Research Issues Short Report On The Co., Says “Arbor Hid Its Toxic Mobile Homes Portfolio To Manipulate Its Stock Price And Avoid Insolvency’
https://ningiresearch.com/2023/03/14/research-report-arbor-realty-trust-inc-nyse-abr/
We are short Arbor Realty Trust, Inc. (NYSE:ABR), because, in our opinion, Arbor hid its toxic mobile homes portfolio to manipulate
Susquehanna Reiterates Positive on SLB, Maintains $68 Price Target
Susquehanna analyst Charles Minervino reiterates SLB (NYSE:SLB) with a Positive and maintains $68 price target.
Susquehanna Reiterates Neutral on RPC, Maintains $50 Price Target
Susquehanna analyst Charles Minervino reiterates RPC (NYSE:RES) with a Neutral and maintains $50 price target.
Citigroup Upgrades LexinFintech Holdings to Buy, Raises Price Target to $3.6
Citigroup analyst Judy Zhang upgrades LexinFintech Holdings (NASDAQ:LX) from Neutral to Buy and raises the price target from $2.31 to $3.6.
Susquehanna Reiterates Positive on Halliburton, Maintains $57 Price Target
Susquehanna analyst Charles Minervino reiterates Halliburton (NYSE:HAL) with a Positive and maintains $57 price target.
Susquehanna Reiterates Neutral on NOW, Maintains $14 Price Target
Susquehanna analyst Charles Minervino reiterates NOW (NYSE:DNOW) with a Neutral and maintains $14 price target.
Sidoti & Co. Reinstates Buy on GATX, Announces $152 Price Target
Sidoti & Co. analyst Brendan McCarthy reinstates GATX (NYSE:GATX) with a Buy and announces $152 price target.
Benchmark Reiterates Buy on Beauty Health, Maintains $23 Price Target
Benchmark analyst Bruce Jackson reiterates Beauty Health (NASDAQ:SKIN) with a Buy and maintains $23 price target.
Citigroup Maintains Neutral on Visteon, Raises Price Target to $165
Citigroup analyst Itay Michaeli maintains Visteon (NASDAQ:VC) with a Neutral and raises the price target from $145 to $165.